IB Acquisition Corp.

IBACR ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-567.2K $-639.9K $-58.9K $866.4K $818.6K $824.1K $907.1K $1.0M
Depreciation & Amortization — — — — — — — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-474.5K $-265.9K $-1.1M $-57.3K $-141.4K $-744.2K $-375.2K $-53.9K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — $106.9M $0 $609.0K $315.0K —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities — — — — — — $147.6K $0
Net Change in Cash — — — — — — — —
Free Cash Flow — — — — — — — —
← Newer Page 1 of 2 Older →